Can You Pass the (Deoxyribonucleic) Acid Test?
By Center for Environmental Health,
Center for Environmental Health [with CGS's Pete Shanks]
| 03. 17. 2014
For just $99, genetic test company 23andme offered to test your DNA for everything from heart disease risk to your chance of going bald. Kira Peikoff wondered what DNA testing from 23andme and two other companies would tell her—and the results were surprising. We’ll also talk to geneticist Dr. David Ng. His story in McSweeny’s, “Congratulations, Your Ineffectual Genetic Test Results Have Arrived” pokes fun at the “direct-to-consumer” genetic testing industry. Then Dr. Stuart Newman fills us in on epigenetics, evolutionary developmental biology, and why the Lamarck versus Darwin debate may be old news. Finally, advocate Pete Shanks on the “promise” of GMO humans and the threat of techno-eugenics.
Check out this episode.
Download here, or subscribe via iTunes.
Kira Peikoff is an author and Masters student in bioethics at Columbia University. Her New York Times article in December exposed the fallacies of direct-to-consumer genetic testing (see more resources on genetic test companies below). Check out her debut novel Living Proof (and look for her upcoming 2nd novel in the fall) on her website.
David Ng is...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...